Envista Holdings Corporation (NYSE:NVST) Shares Bought by New York State Common Retirement Fund

New York State Common Retirement Fund grew its position in shares of Envista Holdings Corporation (NYSE:NVST) by 8.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 450,101 shares of the company’s stock after acquiring an additional 33,855 shares during the quarter. New York State Common Retirement Fund owned about 0.27% of Envista worth $7,769,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of NVST. UMB Bank n.a. lifted its holdings in Envista by 214.4% in the first quarter. UMB Bank n.a. now owns 2,094 shares of the company’s stock worth $36,000 after purchasing an additional 1,428 shares during the period. Mitsubishi UFJ Trust & Banking Corp acquired a new stake in Envista in the fourth quarter worth about $86,000. Palouse Capital Management Inc. lifted its holdings in Envista by 14.4% in the first quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company’s stock worth $163,000 after purchasing an additional 1,186 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Envista by 51.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company’s stock worth $213,000 after purchasing an additional 3,751 shares during the period. Finally, Sterling Capital Management LLC lifted its holdings in Envista by 53.9% in the fourth quarter. Sterling Capital Management LLC now owns 11,105 shares of the company’s stock worth $214,000 after purchasing an additional 3,888 shares during the period.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Bank of America cut their price target on shares of Envista from $26.00 to $23.00 and set a “buy” rating for the company in a report on Tuesday, April 29th. Piper Sandler cut their price target on shares of Envista from $18.00 to $17.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. Baird R W raised shares of Envista from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 27th. Morgan Stanley set a $16.00 price target on shares of Envista in a report on Tuesday, April 15th. Finally, Evercore ISI upped their price target on shares of Envista from $19.00 to $23.00 and gave the company an “outperform” rating in a report on Wednesday, July 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $20.23.

Envista Stock Down 1.5%

Shares of NVST stock opened at $19.46 on Friday. The stock has a market cap of $3.30 billion, a P/E ratio of -2.98, a price-to-earnings-growth ratio of 1.23 and a beta of 1.00. Envista Holdings Corporation has a one year low of $14.22 and a one year high of $23.00. The stock has a fifty day moving average price of $18.91 and a 200 day moving average price of $18.53. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.12 and a quick ratio of 1.82.

Envista (NYSE:NVST) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.04. Envista had a positive return on equity of 4.07% and a negative net margin of 44.90%. The company had revenue of $616.90 million during the quarter, compared to analysts’ expectations of $608.17 million. During the same period last year, the business earned $0.26 earnings per share. The business’s revenue was down 1.1% on a year-over-year basis. Analysts predict that Envista Holdings Corporation will post 1 earnings per share for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.